GO
Loading...

Health Care Equipment and Supplies

More

  • Feb 4- Boston Scientific Corp on Tuesday reported higher-than-expected quarterly results, citing improving demand for its devices that manage irregular heart rhythms. Boston Scientific is also expected to benefit from the introduction of its S-ICD system.

  • Feb 4- Boston Scientific Corp on Tuesday reported higher-than-expected quarterly earnings on higher sales of its implantable devices that manage irregular heart rhythms. Boston Scientific forecast 2014 earnings of 75 cents to 80 cents a share, excluding special items, on revenue of $7.3 billion to $7.5 billion.

  • Boston Scientific earnings up on heart devices Tuesday, 4 Feb 2014 | 7:40 AM ET

    Feb 4- Boston Scientific Corp on Tuesday reported higher fourth-quarter earnings on stronger sales of its implantable devices that manage irregular heart rhythms. The medical device maker said it had earned $108 million, or 8 cents a share, compared with $60 million, or 4 cents a share, a year earlier.

  • Feb 3- U.S. medical device maker Biomet Inc will pay at least $56 million to settle a multi-district lawsuit relating to defective metal hip replacements, a court filing showed, ending a protracted legal tussle. The lawsuits were combined and jointly heard at the federal court of Indiana, the state where Biomet is headquartered.

  • Feb 3- Medical device maker Hologic Inc reported a better-than-expected adjusted quarterly profit as it sold more 3 D systems that help detect breast cancer, and its CEO said he would pursue the strategic review started by his predecessor.

  • Feb 3- Medical device maker Hologic Inc reported a better-than-expected adjusted quarterly profit in part due to higher sales of its 3 D digital mammography systems. Hologic shares rose 4 percent in extended trading.

  • Feb 3- Medical device maker Hologic Inc reported a better-than-expected adjusted quarterly profit, helped by higher sales of its 3 D digital mammography systems. Hologic shares rose 4 percent in extended trading. Excluding items, Hologic earned 34 cents per share, ahead of analysts' average estimate of 31 cents per share, according to Thomson Reuters I/B/E/S.

  • Obamacare Inc: Allies urge White House to tap CEO Monday, 30 Dec 2013 | 7:28 AM ET

    The White House is coming under pressure from some of its closest allies to name a CEO to run its health insurance marketplace.

  • Icahn reports large stake in medical device maker Thursday, 21 Nov 2013 | 10:25 AM ET
    Carl Icahn, billionaire investor and chairman of Icahn Enterprises Holdings LP

    Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover

  • One man, one small business, four billionaires Wednesday, 13 Nov 2013 | 8:00 AM ET

    An entrepreneur has attracted investments from four billionaires: Sam Zell, Herb Simon, David Bonderman and "one family you've never heard of."

  • JNJ to pay $2.2 billion in US probe: Feds Monday, 4 Nov 2013 | 1:53 PM ET

    Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.

  • Prognosis: Healthy earnings for pharma, biotech Tuesday, 16 Jul 2013 | 5:46 PM ET
    A doctor checks a patient who is experiencing flu symptoms.

    Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.

  • Heart Device Approval Delays Leave Doctors Frustrated Monday, 27 May 2013 | 11:33 AM ET

    Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.

  • Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.

  • Patients Scarred After Robotic Surgery Friday, 19 Apr 2013 | 8:58 AM ET
    Da Vinci Surgical robot designed to facilitate complex surgery using a minimally invasive approach.

    Most robotic surgery takes place without a hitch, but a growing number of complaints and lawsuits allege complications and even deaths from Intuitive Surgical's da Vinci device.

  • Marketing Is Key to Surgical Robot’s Success Thursday, 18 Apr 2013 | 8:14 PM ET

    If the critics of robotic surgery are right—that safety is an issue—how is that it was performed on 450,000 people last year? The answer may lie in one word: Marketing.

  • Counting the Problems of Robot-Assisted Surgery Thursday, 18 Apr 2013 | 7:58 PM ET
    Dr. Marty Makary of Johns Hopkins University Hospital

    The number of complications from robot-assisted surgery using Intuitive Surgical's da Vinci robot are underreported, allege critics of the procedure, fanning the controversy around the company's pioneering product.

  • Controversy Over Surgical Robotics Heats Up Thursday, 18 Apr 2013 | 5:05 PM ET
    A surgeon looks through the da Vinci surgical system's monitor.

    Intuitive Surgical's da Vinci robot was once hailed as a revolution in the operating room, but as more reports of complications have come to light, the da Vinci debate is heating up.

  • What Happens When the Surgical Robot Malfunctions? Tuesday, 19 Mar 2013 | 11:08 AM ET

    Like all computers, Intuitive Surgical's da Vinci robot can malfunction during surgery. A range of results have been reported by surgeons.

  • The Da Vinci Code: Growing Sales, Growing Concerns Tuesday, 19 Mar 2013 | 11:04 AM ET

    In recent years, as the surgical robot's popularity has grown, so have questions and concerns about its safety, training and the aggressiveness of its marketing.